PHP
KOD icon

Parkman Healthcare Partners’s Kodiak Sciences KOD Stock Holding History

Parkman Healthcare Partners’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35,174
Closed -$2.98M – 88
2021
Q4 		$2.98M Sell
35,174
-1,528
-4% -$155K 0.66% 42
2021
Q3 		$3.52M Hold
36,702
– – 0.89% 34
2021
Q2 		$3.41M Buy
36,702
+3,654
+11% +$351K 0.75% 44
2021
Q1 		$3.75M Sell
33,048
-16,865
-34% -$2.3M 0.87% 38
2020
Q4 		$7.33M Sell
49,913
-42,820
-46% -$4.77M 1.88% 18
2020
Q3 		$5.49M Buy
92,733
+27,515
+42% +$1.38M 1.45% 27
2020
Q2 		$3.53M Hold
65,218
– – 0.99% 36
2020
Q1 		$3.11M Sell
65,218
-109,320
-63% -$6.56M 1.44% 27
2019
Q4 		$12.6M Buy
+174,538
New +$6.35M 3.63% 5

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkman Healthcare Partners's KOD Position: Q1 2022 in Review

Parkman Healthcare Partners sold out of Kodiak Sciences (KOD) in Q1 2022, closing a stake of 35,174 shares — an estimated $2.98M sold.

Parkman Healthcare Partners first reported a position in KOD in Q4 2019 and held it in 9 quarters. The position peaked at $12.6M in Q4 2019. 142 funds tracked by Wall St. Rank hold KOD as of Q1 2022.

  • Parkman Healthcare Partners reported no remaining Kodiak Sciences position as of Q1 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 35,174 Kodiak Sciences shares in Q1 2022, an estimated $2.98M.
  • Parkman Healthcare Partners first reported a position in Kodiak Sciences in Q4 2019 and held it in 9 quarters.
  • Parkman Healthcare Partners's Kodiak Sciences position peaked at $12.6M in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2022.

Based on Parkman Healthcare Partners's 13F filing for Q1 2022, filed 13 May 2022.